MedicineNet.com
About Us | Privacy Policy | Site Map
November 24, 2009
MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Picture Image Collection MedTerms medical dictionary
Font Size
A
A
A
Disclaimer


SUMATRIPTAN-ORAL TABLET (cont.)

DRUG INTERACTIONS: Certain medications taken with this product could result in serious, even fatal, drug interactions. Do not take MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, procarbazine, selegiline, tranylcypromine) for at least 2 weeks before or after taking this drug. Do not take other "triptan" migraine drugs (e.g., zolmitriptan, rizatriptan) or ergot-type drugs (e.g., dihydroergotamine, ergotamine, methysergide) within 24 hours of taking this medicine. Before using this medication, tell your doctor or pharmacist of all nonprescription and prescription products you may use, especially of: other drugs for prevention or treatment of headaches, "serotonin-type" medications (e.g., SSRI antidepressants such as fluvoxamine, sertraline), medication for weight control. It is recommended to avoid consumption of alcohol while taking this medication. Do not start or stop any medicine without doctor or pharmacist approval.

OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include tremor, chest pain, slowed breathing, and seizures.

NOTES: This medication is used to relieve a migraine attack in progress. It is not effective in preventing migraine attacks.

MISSED DOSE: Take this medication only when a migraine attack occurs as directed. This is not taken routinely. Never "double-up" the dose.

STORAGE: Store this medication at 15 to 30 degrees C (59 to 86 degrees F) away from heat and light. Do not store in the bathroom. Keep this and all medications out of the reach of children.


Last Editorial Review: 3/2/2005




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Printer-Friendly Format  |  Email to a Friend


Suggested Reading by Our Doctors
MedicineNet Doctors
  • Drug Interactions - Learn about potential drug interactions you may be exposed to. Drug interactions can occur with prescription drugs, OTC medication, vitamins, herbs, and supplements.
  • Migraine - Learn about migraine headache including symptoms such as intense throbbing pain in the temple area of head. Migraine triggers vary from person to person.
  • Drugs: What You Should Know About Your Drugs - Find out what you should know about your drugs such as side effects, warnings and precautions, storage information, and if a generic version is as good as the brand name.

Latest Medical News


Back to Medications Index

copyright


Living Better

Find the secrets to longer life.


Are you Depressed? Take the Quiz

Your Guide to Symptoms & Signs: Pinpoint Your Pain





SUMATRIPTAN-ORAL TABLET Related Articles







Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information:
verify here.

©1996-2009 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.